These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 12140563)

  • 1. Screening for drug discovery: the leading question.
    Smith A
    Nature; 2002 Jul; 418(6896):453-9. PubMed ID: 12140563
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug discovery: the leading edge.
    Chapman T
    Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
    [No Abstract]   [Full Text] [Related]  

  • 3. High throughput screening: early successes indicate a promising future.
    Fox S; Wang H; Sopchak L; Khoury R
    J Biomol Screen; 2001 Jun; 6(3):137-40. PubMed ID: 11689109
    [No Abstract]   [Full Text] [Related]  

  • 4. China's unique position in discovery and preclinical research.
    Boutellier R; Ullman F
    Drug Discov Today; 2007 Jan; 12(1-2):4-7. PubMed ID: 17198968
    [No Abstract]   [Full Text] [Related]  

  • 5. Lab automation and robotics: Automation on the move.
    Chapman T
    Nature; 2003 Feb; 421(6923):661, 663, 665-6. PubMed ID: 12571603
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemistry plans a structural overhaul.
    Russo E
    Nature; 2002 Sep; 419(6903):4-7. PubMed ID: 12226620
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug target validation: Hitting the target.
    Smith C
    Nature; 2003 Mar; 422(6929):341, 343, 345 passim. PubMed ID: 12646927
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for content--the evolution of high throughput.
    Dove A
    Nat Biotechnol; 2003 Aug; 21(8):859-64. PubMed ID: 12894197
    [No Abstract]   [Full Text] [Related]  

  • 9. Building biomanufacturing capacity--the chapter and verse.
    Kamarck ME
    Nat Biotechnol; 2006 May; 24(5):503-5. PubMed ID: 16680126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connecting genes, drugs and diseases.
    Weinstein JN; Pommier Y
    Nat Biotechnol; 2006 Nov; 24(11):1365-6. PubMed ID: 17093484
    [No Abstract]   [Full Text] [Related]  

  • 11. A testing approach based on tiny doses still awaits big results.
    Coombs A
    Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685584
    [No Abstract]   [Full Text] [Related]  

  • 12. Break with tradition.
    Jayaraman KS
    Nature; 2006 Jul; 442(7101):342-3. PubMed ID: 16871181
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Little biotech on the prairie.
    Wolfson W
    Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of data fusion methods in virtual screening: similarity and group fusion.
    Whittle M; Gillet VJ; Willett P; Loesel J
    J Chem Inf Model; 2006; 46(6):2206-19. PubMed ID: 17125165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug screening--beyond the bottleneck.
    Dove A
    Nat Biotechnol; 1999 Sep; 17(9):859-63. PubMed ID: 10471925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug target identification: a question of biology.
    Smith C
    Nature; 2004 Mar; 428(6979):225-31. PubMed ID: 15014514
    [No Abstract]   [Full Text] [Related]  

  • 18. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 19. Rising costs hold up drug discovery.
    Miller HI
    Nature; 1998 Oct; 395(6705):835. PubMed ID: 9804407
    [No Abstract]   [Full Text] [Related]  

  • 20. Lead validation platforms.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT47-9. PubMed ID: 11221718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.